{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:42:48Z","timestamp":1789587768670,"version":"build-2803163510"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To study the therapeutic variations of biologic and targeted synthetic DMARDs (b\/tsDMARDs) between genders and across age stages in axial SpA (axSpA) patients through meta-analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Randomized controlled trials published by PubMed, Scopus and Embase before 10 August 2023, testing the efficacy of b\/tsDMARDs in axSpA, were searched and systematically reviewed. The Assessment of Spondyloarthritis International Society \u226540% improvement (ASAS40) was used as the primary outcome of treatment response.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Only one study meet the inclusion criteria related to tsDMARDs, which was excluded from further analysis. Nine studies of bDMARDs, with 4127 patients, were included for the final analysis. When compared with placebo, both males [odds ratio (OR) 3.14 (95% CI 2.66, 3.70)] and females [OR 2.32 (95% CI 1.82, 2.82)] and younger [OR 4.00 (95% CI 2.50, 6.40)] and older [OR 2.21 (95% CI 1.15, 4.22)] patients presented significantly better responses to bDMARDs. Also, the efficacies were more evident in males [OR 1.89 (95% CI 1.56, 2.30)] and younger [OR 2.07 (95% CI 1.42, 3.02)] patients. Subgroup analysis revealed that the gender difference in efficacy was more obvious in non-radiographic axSpA (nr-axSpA) patients (Pheterogeneity\u2009=\u20090.03, I2\u2009=\u200978.1%). Moreover, males with radiographic axSpA (r-axSpA) and nr-axSpA shared similar responses to bDMARDs (Pheterogeneity\u2009=\u20090.87, I2\u2009=\u20090%), while females with r-axSpA showed greater response than those with nr-axSpA (Pheterogeneity\u2009=\u20090.005, I2\u2009=\u200987.4%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The bDMARDs were efficacious in all axSpA patients regardless of gender or age. However, the treatment responses were more evident in male and younger patients. Also, females with r-axSpA had greater responses than those with nr-axSpA, whereas no relevant difference was observed in males, indicating that the gender difference on efficacy was greater in nr-axSpA patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae088","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T06:35:47Z","timestamp":1707201347000},"page":"2914-2922","source":"Crossref","is-referenced-by-count":11,"title":["Effect of gender and age on bDMARD efficacy for axial spondyloarthritis patients: a meta-analysis of randomized controlled trials"],"prefix":"10.1093","volume":"63","author":[{"given":"Yan","family":"Xie","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Tsinghua Clinical Research Institute, School of Medicine, Tsinghua University , Beijing,","place":["China"]},{"name":"Office of Clinical Trial Institute, Beijing Tsinghua Changgung Hospital , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"2024110419232286500_keae088-B1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2024110419232286500_keae088-B2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41584-022-00833-0","article-title":"Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis","volume":"18","author":"Stovall","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2024110419232286500_keae088-B3","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1007\/s10067-022-06228-6","article-title":"The impact of gender and sex on diagnosis, treatment outcomes and health-related quality of life in patients with axial spondyloarthritis","volume":"41","author":"Marzo-Ortega","year":"2022","journal-title":"Clin Rheumatol"},{"key":"2024110419232286500_keae088-B4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11926-018-0744-2","article-title":"Gender Differences in Axial Spondyloarthritis: women Are Not So Lucky","volume":"20","author":"Rusman","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"2024110419232286500_keae088-B5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11926-013-0374-7","article-title":"Spondyloarthritis with onset after age 45","volume":"15","author":"Olivieri","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"2024110419232286500_keae088-B6","first-page":"e39100","article-title":"Characteristics of late-onset spondyloarthritis: data from the Moroccan registry of biological therapies in rheumatic diseases","volume":"15","author":"Mougui","year":"2023","journal-title":"Cureus"},{"key":"2024110419232286500_keae088-B7","first-page":"351","article-title":"Effect of age at disease onset in the clinical profile of spondyloarthritis: a study of 1424 Brazilian patients","volume":"30","author":"Skare","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"2024110419232286500_keae088-B8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41584-022-00761-z","article-title":"Treatment of axial spondyloarthritis: an update","volume":"18","author":"Danve","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2024110419232286500_keae088-B9","doi-asserted-by":"crossref","first-page":"m4447","DOI":"10.1136\/bmj.m4447","article-title":"Axial spondyloarthritis: new advances in diagnosis and management","volume":"372","author":"Ritchlin","year":"2021","journal-title":"BMJ"},{"key":"2024110419232286500_keae088-B10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13293-020-00301-y","article-title":"The impact of sex and gender on immunotherapy outcomes","volume":"11","author":"Klein","year":"2020","journal-title":"Biol Sex Differ"},{"key":"2024110419232286500_keae088-B11","doi-asserted-by":"crossref","first-page":"152078","DOI":"10.1016\/j.semarthrit.2022.152078","article-title":"Predictors of remission in people with axial spondyloarthritis: a systematic literature review","volume":"56","author":"Pinto","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2024110419232286500_keae088-B12","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2024110419232286500_keae088-B13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13075-021-02650-4","article-title":"Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol","volume":"23","author":"Maksymowych","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2024110419232286500_keae088-B14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/annrheumdis-2012-201766","article-title":"Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)","volume":"72","author":"Sieper","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2024110419232286500_keae088-B15","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/art.23606","article-title":"Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two","volume":"58","author":"Haibel","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2024110419232286500_keae088-B16","doi-asserted-by":"crossref","first-page":"275.1","DOI":"10.1136\/annrheumdis-2015-eular.2817","article-title":"Baseline demographic and disease characteristics associated with response to golimumab in patients with active nonradiographic axial spondyloarthritis","volume":"74","author":"Dougados","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2024110419232286500_keae088-B17","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/annrheumdis-2017-211313","article-title":"Evaluation of the effect of baseline MRI sacroiliitis and C reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: a post hoc analysis of the EMBARK study","volume":"77","author":"Brown","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2024110419232286500_keae088-B18","article-title":"Impact of time since diagnosis, age, and number of prior non-steroidal anti-inflammatory drugs on 52-week clinical response to adalimumab in patients with ankylosing spondylitis [abstract]","volume":"69(Suppl 10):1\u20133","author":"Sieper","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2024110419232286500_keae088-B19","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s40744-021-00380-2","article-title":"A pooled analysis reporting the efficacy and safety of secukinumab in male and female patients with ankylosing spondylitis","volume":"8","author":"van der Horst-Bruinsma","year":"2021","journal-title":"Rheumatol Ther"},{"key":"2024110419232286500_keae088-B20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13075-021-02613-9","article-title":"Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT","volume":"23","author":"Braun","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2024110419232286500_keae088-B21","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1007\/s12325-022-02132-2","article-title":"Baseline characteristics and treatment response to ixekizumab categorised by sex in radiographic and non-radiographic axial spondylarthritis through 52 weeks: data from three phase III randomised controlled trials","volume":"39","author":"van der Horst-Bruinsma","year":"2022","journal-title":"Adv Ther"},{"key":"2024110419232286500_keae088-B22","article-title":"Influence of baseline demographics on improvements in disease activity measures in patients with ankylosing spondylitis receiving upadacitinib: a post hoc subgroup analysis","volume":"73(Suppl 9):1\u20135","author":"Van den Bosch","year":"2021","journal-title":"Arthritis Rheum"},{"key":"2024110419232286500_keae088-B23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2024110419232286500_keae088-B24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1756-185X.2011.01687.x","article-title":"Distinct impacts of syndesmophyte formation on male and female patients with ankylosing spondylitis","volume":"15","author":"Huang","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"2024110419232286500_keae088-B25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/art.39464","article-title":"Sexual dimorphism in the Th17 signature of ankylosing spondylitis","volume":"68","author":"Gracey","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2024110419232286500_keae088-B26","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/acr.22001","article-title":"Differences between women and men with recent-onset axial spondyloarthritis: results from a prospective multicenter French cohort","volume":"65","author":"Tournadre","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2024110419232286500_keae088-B27","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1136\/ard.2011.152975","article-title":"HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis","volume":"70","author":"Chung","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2024110419232286500_keae088-B28","doi-asserted-by":"crossref","first-page":"iv38","DOI":"10.1093\/rheumatology\/keaa543","article-title":"Sex and gender differences in axial spondyloarthritis: myths and truths","volume":"59","author":"Rusman","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2024110419232286500_keae088-B29","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.metabol.2010.07.013","article-title":"Pain: sex differences and implications for treatment","volume":"59(Suppl 1)","author":"Manson","year":"2010","journal-title":"Metabolism"},{"key":"2024110419232286500_keae088-B30","doi-asserted-by":"crossref","first-page":"116926","DOI":"10.1016\/j.lfs.2019.116926","article-title":"Sex differences in pain and opioid mediated antinociception: modulatory role of gonadal hormones","volume":"237","author":"Nasser","year":"2019","journal-title":"Life Sci"},{"key":"2024110419232286500_keae088-B31","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/jnr.23841","article-title":"Sex differences in pain","volume":"95","author":"Sorge","year":"2017","journal-title":"J Neurosci Res"},{"key":"2024110419232286500_keae088-B32","doi-asserted-by":"crossref","first-page":"e001108","DOI":"10.1136\/rmdopen-2019-001108","article-title":"Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis","volume":"5","author":"L\u00f3pez-Medina","year":"2019","journal-title":"RMD Open"},{"key":"2024110419232286500_keae088-B33","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.semarthrit.2016.09.002","article-title":"Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritis","volume":"46","author":"Sieper","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2024110419232286500_keae088-B34","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/annrheumdis-2014-205322","article-title":"Efficacy of TNF\u03b1 blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis","volume":"74","author":"Callhoff","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2024110419232286500_keae088-B35","doi-asserted-by":"crossref","first-page":"1059173","DOI":"10.3389\/fimmu.2022.1059173","article-title":"Immune system modulation in aging: molecular mechanisms and therapeutic targets","volume":"13","author":"Cisneros","year":"2022","journal-title":"Front Immunol"},{"key":"2024110419232286500_keae088-B36","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1136\/annrheumdis-2018-214918","article-title":"Effect of disease duration and prior disease-modifying antirheumatic drug use on treatment outcomes in patients with rheumatoid arthritis","volume":"78","author":"Aletaha","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2024110419232286500_keae088-B37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/mr\/roab003","article-title":"Drug efficacy and safety of biologics and Janus kinase inhibitors in elderly patients with rheumatoid arthritis","volume":"32","author":"Ebina","year":"2022","journal-title":"Mod Rheumatol"},{"key":"2024110419232286500_keae088-B38","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/14712598.2018.1504016","article-title":"An overview of the efficacy and safety of systemic treatments for psoriasis in the elderly","volume":"18","author":"Di Lernia","year":"2018","journal-title":"Expert Opin Biol Ther"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae088\/56793517\/keae088.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/11\/2914\/60415646\/keae088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/11\/2914\/60415646\/keae088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T19:23:33Z","timestamp":1730748213000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/11\/2914\/7601351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,2,6]]},"published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae088","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,2,6]]}}}